Published in Gene Therapy Weekly, January 25th, 2007
Tardugno brings extensive pharmaceutical industry leadership experience to Celsion. He joined Mylan Laboratories, Inc (MYL) in February 2005 as senior vice president and general manager of Mylan Technologies Inc, a subsidiary whose technology focuses on transdermal drug delivery systems. From 1998 to 2005 he was executive vice president and a founding member of management of Songbird Hearing, Inc, where he forged a number of significant agreements with major U.S. and International partners in the development and commercialization of the world's first...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.